Here’s how to achieve diversity in STEM – and why it matters
So far over 10 million patients worldwide have benefited from the diagnostic tests for cancer and infectious diseases created by Cicada Innovations incubatee, SpeeDx. In Australia, over 80% of laboratories are also using at least one SpeeDx test to report patient samples. And when COVID-19 hit, the company also manufactured COVID-19 tests and supplied them… Read more »